LabCompass

Bryan P. Schneider

Medicine · Indiana University

OpenAlex ORCID
Established · publishing since 1970Rising activity
Radiomics and Machine Learning in Medical ImagingCancer Treatment and PharmacologyCancer, Hypoxia, and MetabolismCancer Research and TreatmentsBreast Cancer Treatment Studies

Publications

528

Citations

11,808

Est. group size

~1

Recurring co-author estimate

Active years

57

Publishing since 1970

Research summary
AI-generated

Bryan P. Schneider conducts clinical and translational cancer research, with a strong focus on breast cancer (especially triple-negative breast cancer) and how patients' genetics influence treatment outcomes. A major theme is understanding and predicting taxane-induced peripheral neuropathy (nerve damage caused by common chemotherapy drugs), including racial disparities in this side effect. The work spans early-phase clinical trials of new drug combinations, genomic and immune profiling of tumors, and biomarkers for tailoring therapy.

Breast cancer treatment, especially triple-negative diseaseChemotherapy-induced peripheral neuropathy and its genetic predictorsPharmacogenomics and precision oncologyEarly-phase clinical drug trialsTumor genomics and immune profiling

Publication activity grew substantially over the decade, peaking sharply around 2023-2024 before a lower count in the partial 2025-2026 years, with a high recent average of about 61 papers per year.

Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026

Funding
Public award records

No award with a current end date on record.

3 earlier awards
  • NIH R01CA203737Apr 2016 – Apr 2026 · $525k awarded

    Targeting HER2-low breast cancer with 17p loss

  • NIH R01CA155311Sep 2011 – Jul 2015 · $303k awarded

    VEGF Gene Amplification/Haplotype as Biomarkers for Bevacizumab in Breast Cancer

  • NIH M01RR000750Dec 2005 – May 2008 · $0k awarded

    CYTOCHROME P450 PHARMACOGENETICS AS A PREDICTOR OF TOXICITY AND CLINICAL EFFICAC

Matched to public NIH RePORTER and NSF records by name and institution. Awards from other agencies are not shown, and a match is not always found — this list may be incomplete.

In context
Among 5,073 established Medicine PIs within our index
Citations: 11,808cohort median 2,525
h-index: 47cohort median 24
Publications / year (recent): 61.0cohort median 4.8

Typically publishes in teams of ~21 · 2% small-team papers (≤3 authors) · across 71 venues

Publication cadence
Publications per year over the last 10 years — averaging 61.0/year recently
2017: 16 publications172018: 19 publications182019: 10 publications192020: 30 publications202021: 21 publications212022: 17 publications222023: 70 publications232024: 144 publications144242025: 66 publications252026: 8 publications26
Collaborators per year
Distinct co-authors at Indiana University each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
2017: 0 collaborators at the same institution2018: 14 collaborators at the same institution2019: 0 collaborators at the same institution2020: 10 collaborators at the same institution2021: 10 collaborators at the same institution2022: 18 collaborators at the same institution2023: 1 collaborator at the same institution2024: 1 collaborator at the same institution2025: 6 collaborators at the same institution1719212325
Recent publications
Publishes in
  • Journal of Clinical Oncology×37
  • Cancer Research×25
  • JCO Precision Oncology×10
  • Clinical Cancer Research×7
  • Breast Cancer Research and Treatment×6
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Sep 1, 2026.

Claim or correct this profile